Steroid utility, immunotherapy, and brain tumor management: an update on conflicting therapies.
Ontology highlight
ABSTRACT: Steroid use is a widely accepted practice for both the treatment and prevention of tumor-induced edema, but there are many unknowns regarding their current clinical utility with modern anti-tumor therapies. This decreases edema and relieves the symptomatic mass effect. There are clearly understood benefits and commonly accepted complications of methylprednisolone (MP) use, but the topic is recently controversial. With immunotherapy advancing, a robust immune response is crucial for full therapeutic efficacy. The immunosuppression of MP may interfere with future and current therapeutics relying on the integrity of the patient's immune system. This further emphasizes the need for alternative agents to effectively treat tumor-induced cerebral edema. This review highlights the current clinical
SUBMITTER: Goldman M
PROVIDER: S-EPMC9630032 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA